Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

KORU Medical Systems (KRMD) Gains from Investment Securities (2020 - 2025)

KORU Medical Systems has reported Gains from Investment Securities over the past 11 years, most recently at $27117.0 for Q4 2025.

  • Quarterly results put Gains from Investment Securities at $27117.0 for Q4 2025, up 270.98% from a year ago — trailing twelve months through Dec 2025 was $62010.0 (up 0.53% YoY), and the annual figure for FY2025 was $274508.0, down 89.78%.
  • Gains from Investment Securities for Q4 2025 was $27117.0 at KORU Medical Systems, down from $3.2 million in the prior quarter.
  • Over the last five years, Gains from Investment Securities for KRMD hit a ceiling of $3.6 million in Q1 2022 and a floor of -$15860.0 in Q4 2024.
  • Median Gains from Investment Securities over the past 5 years was $298125.0 (2024), compared with a mean of $1.2 million.
  • Biggest five-year swings in Gains from Investment Securities: skyrocketed 427988.24% in 2022 and later tumbled 159.46% in 2024.
  • KORU Medical Systems' Gains from Investment Securities stood at $1796.0 in 2021, then surged by 1391.54% to $26788.0 in 2022, then fell by 0.43% to $26673.0 in 2023, then tumbled by 159.46% to -$15860.0 in 2024, then soared by 270.98% to $27117.0 in 2025.
  • The last three reported values for Gains from Investment Securities were $27117.0 (Q4 2025), $3.2 million (Q3 2025), and $189006.0 (Q2 2025) per Business Quant data.